Detalles de la búsqueda
1.
Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers.
Nat Cancer
; 2024 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38565920
2.
Cancer lineage-specific regulation of YAP responsive elements revealed through large-scale functional epigenomic screens.
Nat Commun
; 14(1): 3907, 2023 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37400441
3.
Identification of FAM181A and FAM181B as new interactors with the TEAD transcription factors.
Protein Sci
; 29(2): 509-520, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31697419
4.
A new perspective on the interaction between the Vg/VGLL1-3 proteins and the TEAD transcription factors.
Sci Rep
; 10(1): 17442, 2020 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33060790
5.
Author Correction: Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers.
Nat Cancer
; 2024 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38886525
6.
Dissection of the interaction between the intrinsically disordered YAP protein and the transcription factor TEAD.
Elife
; 62017 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28430104
7.
Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ.
Protein Sci
; 26(12): 2399-2409, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28960584
8.
The tyrosine phosphatase PTPN14 is a negative regulator of YAP activity.
PLoS One
; 8(4): e61916, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23613971
Resultados
1 -
8
de 8
1
Próxima >
>>